Activation of human dendritic cells through CD40 cross-linking by unknown
Activation os Human Dendritic Cells 
through CD40 Cross-I;nking 
By Christophe Caux, Catherine Massacrier, B6atrice Vanbervliet, 
Bertrand Dubois, Cees Van Kooten, Isabelh Durand, 
and Jacques Banchereau 
From Schering-Plough,  Laboratory for Immunological  Research, 69571  Dardill 7, France 
Sllmm~'y 
Dendritic cells, the professional antigen-presenting  cells (APC) involved in T cell priming, express 
CD40, a molecule which triggering plays a key role in B cell growth and differentiation as well 
as monocyte activation. Herein we demonstrate that dendritic Langerhans cells (D-I.c) generated 
by culturing cord blood CD34 + progenitor cens with granulocyte/macrophage colony-stimu- 
lating and tumor necrosis factor oe (TNF-c~) express functional CD40 at a density higher than 
that found on B cells. Culturing D-IX on CD40-ligand (CD40L) transfected L cells allowed 
D-IX survival as 50  •  15% of seeded cells were recovered after 4 d while only 5% survived 
over control L cells. CD40 activation induced important morphological changes with a reduction 
of cytoplasmic content and a remarkable increase of dendrite development as well as an altered 
phenotype. In particular, CD40 triggering induced maintenance of high levds of major histo- 
compatibility complex class II antigens and upregulation of accessory molecules such as CD58, 
CD80 (B7-1) and CD86 (B7-2).  CD40 engagement also seems to turn on D-IX maturation 
as illustrated by upregulation of CD25, a molecule usually expressed on interdigitating dendritic 
cells of secondary lymphoid organs. Finally, CD40 activated D-IX secreted a limited set of cytokines 
(TNF-c~, IL-8, and macrophage inflammatory protein 1,', [MIP-loc]) whereas a similar activation 
induced dutriated monocytes to secrete IL-lot, IL-1/5, IL-6, IL-8, IL-10, TNF-~x, and MIP-lo~. 
As D-Ix activated T cells upregulated CD40L, it is likely that CD40 activation olD-ix observed 
herein with a fibroblast cell line stably expressing CD40L, mimics physiological interactiom between 
dendritic cells and T  cells. 
T 
he CD40 antigen (1, for review) was identified by mono- 
donal antibodies reacting with carcinomas and B cells 
(2) and showing costimulatory effects for B lymphocytes (3). 
It is a 50-kD glycoprotein which bdongs to the TNF receptor 
superfamily (4). Cross-linking of CD40, in conjunction with 
IL-4, was found to induce B cells to undergo long-term 
growth, as well as isotype switching, whereas addition of 
IL-10 results in B cell differentiation as well as isotype switch 
(5-8). The use of a CD40-~ fusion protein allowed the iso- 
lation of a cDNA encoding for a CD40 ligand (CD40L) 1, 
a new member of the TNF superfamily mainly expressed on 
activated T cells (9). Interaction between CD40 and CD40L 
has now been shown in vitro to be essential during T cell-de. 
pendent B cell activation (10, 11). In vivo studies in mice 
have demonstrated that an antibody to CD40L can inhibit 
primary and secondary antibody production and establish- 
1 Abbreviations used in this paper:. CD40-L, CD40 ligand; D-Lc, dendritic 
I.angerham  cells;  HPC, hematopoietic  ceils;  ICAM-1,  inte~cdlular  adhesion 
molecule 1; MFI, mean fluorescences  intensities;  MIP-lot, mac~ophage 
inflan~aatory protein lot. 
merit Of  B cell memory (12). The crucial role of CD40/CZ)40L 
in humoral responses in human is further demonstrated in 
patients suffering f~om hyper-IgM syndrome which is charac- 
terized by genetic alterations of the CD40L gene localized 
on chromosome X, leading to the critical lack of circulating 
IgG and IgA and the absence of germinal centers (D-17). 
Functional CD40 molecules were found to be expressed on 
cells other than mature  B cells. In particular, upon CD40 
cross-llnklng, human progenitor B lymphocytes  express CD23 
and proliferate in response to IL-3 (18). Thymic epithelial 
cells secrete GM-CSF in response to CD40 engagement (19). 
Finally, monocytes  express high leveh of CD40 after eq,  osure 
to IFN-% IL-3, and GM-CSF and CD40 cross-llnklng in- 
duces cytokine secretion as well as cytotonicity (20).  Since 
cultured Langerhans cells, as well as circulating and inter- 
digitating dendritic cells, the professional antigen presenting 
ceils involved in T cell priming (21), express CD40 (22, 23), 
we wondered whether dendritic cell CD40 would be func- 
tional. To this end, we studied the biological effects of CD40- 
L-transfected  L cells on human dendritic Langerhans cells 
(D-Ix) generated in vitro by culturing human CD34 + he- 
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(24). CD40 triggering was found to induce survival and mor- 
phological changes of D-Lc. In addition, CD40 engagement 
signals  D-Ix to upmgulate __~es__sory  molecules such as CD58, 
B7-1 (CD80), and  B7-2 (CD86) and  to  secrete  a  limited  set 
of  cytokines  (TNF-a, IL-8,  and macrophagc inflammatory 
protein  la [MIP-la]). 
Mamriah and Methods 
Hematopo/etic Factors.  Recombinant  human (rh)GM-CSF  (sp 
act, 2  x  106 U/rag; Schering-Plough  Research Institute,  Kenil- 
worth, NJ) was used at a saturating concentration  of 100 ng/ml 
(200 U/ml). rhTNF-a (sp act, 2  x  107 U/rag; Genzyme Corp., 
Cambridge,/viA) was used at an optimal concentration of 2.5 ng/ral 
(50 u/~) (2s). 
Collection and Purification of Cord Blood CD34 + Cells.  Umbil- 
ical cord  blood  samples  were  obtained  according  to  institutional 
guidelines. Cells bearing CD34 antigen were isolated from nonad- 
heie~t  mononudear fractions through positive ~_ection by indirect 
immune "panning" using anti-CD34 mAb (Imu-133.3;  Im- 
munotech,  Marsdlle,  France).  A second  pufifa:ation  step  was  per- 
formed using a cocktail of mAbs and immunomagnetic  beads (Dy- 
nabeads M450; Dynal, Oslo, Norway),  as described (26). Thus, 
in  all experiments  the isolated  cells were 95-99%  CD34 + as 
judged by staining with anti-CD34  mAb. 
Purification of Adult ~ripheral Blood T cells and Monocytes 
T cells.  Mononudear cells were isohted from adult peripheral 
blond  and depleted  of  adherent  cells.  Total T lymphocyms were 
then  purified  by immunomagnetic depletion  using  a  cocktail  of 
mAbs IOM2 (CD14),  ION16 (CD16),  ION2 (HLA-DR) (Im- 
munotech),  NKH1 (CD56) (Ortho  Diagnostic  Systems,  Raritan, 
NJ), 4(37 (CD19),  and mAb 89 (CD40) (27). After two rounds 
of bead depletion, the purity of total T cells was routinely higher 
than  95%. 
Monocyte~  Total  PBMC were isohted from healthy donors by 
Hcoll-Hypaque centrifugation; monocytes were isohted by dutrial 
centrifugation.  The preparation was >90% pure as controlled by 
flow  cytometry  with  FITC-conjugated anti-CD14 (Lcu-M3; Becton 
Dickinson  & Co., Mountain  View, CA) and by May Grflnwald 
Giemsa staining. 
Generation of D-Lc from  CD34 + HPC.  Cultures  were estab- 
lished in the presence of GM-CSF and TNF-cz in medium con- 
sisting of R.P/Vli 1640 (GIBCO BILL, Gaithersburg,  MD) sup- 
plemented  with  10%  (vol/vol)  PCS,  10  mM  Hepes,  2  mM 
L-ghtamine, 5  x  10  -s M 2-mercaptoethanol, 100 U/ml penidllin, 
and 100/~g/ml streptomycin  (referred to as complete  medium). 
CD34 + ceils were seeded for expansion in 24-well culture-phtes 
(Linbro; How Laboratories In~, McLean, VA) at 2  x 104 cells/rnl. 
Optimal conditiom were maintained by splitting these cultures every 
4-5 d. CeiLs were routindy collected at day 12 when the cultures 
contained be~  40 and 80% of CDla + dendritic cells indiMing 
Langerhans cells that express Birbeck granules (24). These cultured 
cells witl be referred to as D-Ix throughout the text. For certain 
experiments, a second purification step was performed by FACS  | 
sorting 0~ecton Dickinson & Co.) according to CDla expression. 
CDla § Cells FAC50 Sorting.  For certain  experiments,  after 
12 d of culture in the presence of GM-CSF+TNF-ot  cells gener- 
ated from CD34 + hematopoietic progenitor cells (HPC) were col- 
lected and labeled with FITC-conjugated  OKT6 (CDla) (Ortho 
Diagnostic Systems)  and PE-conjugated Leu-M3 (CD14). Cells were 
separated according to CDla and CD14 expression into CD1a- 
CD14*  and CD1a+CD14 -  fractions using a FACStar  ~ (Becton 
Dickinson & Co.). The procedure of staining and sorting was per- 
formed in presence of 5 mM ~  in order to avoid cell aggrega- 
tion. Reanalysis of the sorted populations showed a purity higher 
than  98%. 
CD40 Act/vat/on.  L cells transfected with the ligend for human 
CD40 (van Kooten, C., and I. Banchereau, manuscript in prepara- 
tion, and reference 28) (CD40L L cells), were used to induce CD40 
triggering  on D-Lc. CD32 transfected L cens (CD32 L cells) were 
used for control cultures. 2.5  x  104 L cells were seeded together 
with  5 x  10  s  calls  (either  total  GM-CSF+TNF-ot  calls, 
CD1a+CD14 -  cells, or elutriated  monocytes) per well (24-well 
culture plate; Linbro; Flow Laboratories Inc.) in presence or ab- 
sence of GM-CSF (100 ng/ml) in 1 ml culture medium and cul- 
tured for 2-4 d. Cell survival was monitored  by enumeration  of 
cells exdnding "ll'ypan blue. For determination of cytokine produc- 
tion, supernatants were recovered after 48 h. For phenotypic  and 
morphological  analysis, cells were recovered after 4 d of culture. 
Cytofluorimetric Cell Sug~ce Pheno?ping.  Indirect  immuno- 
fluorescence was performed uxoMing to standard techniques, using 
a panel of routine mAbs rmealed by PE-conjugated sheep F(ab')z 
anti-mouse immunoglobulin (Ortho Diagnostic Systems). Double- 
color fluorescence was can'ied out by sequential incubation of ceils 
with unconjugeted mAbs, PE-conjugated anti-mouse immunoglob- 
ulin, normal mouse serum, and OKT6 (CDla) or Leu-M3 (CD14) 
mAbs directly labded with FFIC. Negative controls were performed 
with unrelated murine mAhs. Indirect mAbs used were as follows: 
anti-CD11b, anti-CD14, anti-CD15, anti-CD16 (Becton Dickinson 
& Co.);  anti-CDlla,  anti-CD23,  anti-CD25,  anti-CD32,  anti- 
CD54, anti-CD58,  anti-HLA-DR, anti-HLA-DP, anti-HLA-DQ 
(Immunotech); anti-CD11c, anti-CD18 (Dakopats, Glostrup, Den- 
mark),  anti-CD40  (27),  anti-CDS0  (29),  and  anti-CD86  (30). 
Fluorescence analysis was determined  with a FACScan  |  (Becton 
Dickinson  & Co.). 
Cytokine Determination.  Cytokine concentrations  in dendritic 
cell supernatants were measured by two-site sandwich ELISAS, as 
previously described for II,4 (31), Ib6, GM-CSF, and ID10 0 2) 
(sensitivities,  50 pg/ml).  Kits  of dosage  were purchased  from 
Medgenix Diagnostics  (Brussels, Belgium) for TN1La and ID8; 
Immunotech for I~la and ID1/~; and I~D Systems (Minneapolis, 
MN) for MIP-lcz. 
l~ults 
D-Lc Express CD40 which Cross-linking Induces Their Sur- 
viral and Triggers Morphological Changes.  CD40 is expressed 
spontaneously or upon activation on most APC including 
B cells (3), monocytes (20), and dendritic cells (22). Accord- 
ingly, we wondered whether D-I.c generated by culturing 
cord  blood  CD34 +  cells  for  12  d  in  presence  of GM- 
CSF+TNF-ot (later on referred to as 12-d D-Lc), expressed 
CD40 as measured by double staining USing anti-CD40 and 
anti-CDla mAbs. As shown in Hg.  1, all CDla + D-Lc ex- 
pressed high levels of CD40. The intensity of CD40 expres- 
sion on D-Lc was three- to fourfold higher than that of freshly 
isolated tonsil B cells (not shown).  Note that a significant 
proportion of cultured cells expressed CD40 without CDla. 
We next wondered whether CD40 cross-linking  would 
affect D-Ix. Thus, cultured D-Lc were incubated with CD40L 
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Figure 1.  In vi~ted  D-I.c empress  CD40. D-l.c gencnted, after 
12 d of culture of CD34 § cord blood H1)C in the presence of GM- 
CSF+TNF-~, we~ processed  for double  staining. Cells  were labeled  with 
anti-CD40 (mAb 89) revealed  by PE-conjugated anti-mouse Ig followed 
by FITC anti-CDla (OKT6) after saturation in 2% mouse serum. A shows 
isotype controls and B shows CDla/CD40 stain;rig. 
or CD32 (as a negative control) transfected L cells with or 
without  100 ng/ml  GM-CSF and cell viability was deter- 
mined 2 and 4 d later by trypan blue exclusion. As shown 
in Fig. 2, in the absence of GM-CSF, D-Ix cultured on CD32 
L cells died rapidly with 50% recovery (range 40-75, n  - 
6) after 2 d of culture and 3% recovery (range 1.3-3.7, n  - 
6) after 4 d.  Upon CD40 triggering  (without  GM-CSF), 
the recovery was 75% (range 65-100, n  -  6) after 2 d and 
40% (range 32-65, n  -~ 6) after 4 d. In presence of GM-CSF 
and CD32 L cells,  no major decrease in D-Ix viability was 
observed after 2 d (recovery range 75-80, n  =  6), but a cell 
viability reduced to 50% was observed after 4 d (range 50-56, 
n  =  6). A  combination of CD40 triggering and GM-CSF 
resulted  in  sustained  cell viability detected both  after 2  d 
(recovery range 95-100, n  -- 6) and after 4 d (recovery range 
75-80, n  =  6). In presence of CD40L L cells and GM-CSF, 
D-Ix can be maintained without major cell loss for at least 
one week (not shown).  TNF-(x was not included in those 
experiments as pilot studies indicated its lack of effect on the 
survival of 12 day D-Ix (not shown). 
During  the  culture,  morphological  changes  could  be 
identified by simple phase contrast microscope observation. 
In the absence of GM-CSF, cells died when cultured on CD32 
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Figure 2.  CD40  triggering allows survival of D-I.c. 12-d D-I.c were 
cultured for 4 d either on control L cells  or CD40L L cens, in the presence 
or absence  of GM-CSE At the indicated time points, cells were harvested 
and counted. The results are representative of six experiments. 
L cells (Fig. 3 A) whereas CD40L activated D-IX survived 
and developed extensive dendrites (Fig. 3 B). The morphology 
of D-Lc cultured for 4 d in presence of GM-CSF on CD32 
or CD40L  L  cells  is shown after May Griinwald  Giemsa 
staining.  Most D-IX cultured on CD32 L cells with GM- 
CSF appeared as large cells with very small dendrites at the 
membrane surface (Fig. 4 A). In contrast, D-IX cultured on 
CD40L L cells with GM-CSF appeared as a homogenous 
population of smaller cells with a lower cytoplasm/nucleus 
ratio but with a very dense and uniform system of dendrites 
at the membrane surface (Fig. 4 B). This system of dendrites 
represented a very strong extension of the plasma membrane 
surface when compared with unactivated D-IX. These mor- 
phological changes, similarly observed in absence of GM-CSF 
(not shown) were thus due to CD40 triggering. 
These experiments demonstrate that CD40 cross-ll,king 
signals D-Ix. 
CD40-activated D-Lc Upregulate Accessory Molecules and 
CD25/Ta~  As CD40 triggering on D-Ix is likely to occur 
during an interaction  with T  cells,  we wondered whether 
such signaling would induce modulation of accessory mole- 
cules on the D-Ix surface. 12-d D-Ix were incubated on either 
CD40-L or CD32 transfected L cells, in presence of GM-CSF 
in order to maintain cell viability. After 4 d of culture, cells 
were double stained with a panel of mAbs revealed by PE- 
conjugated goat anti-mouse Ig then anti-CDla FITC mAb. 
Fig. 5 shows the phenotype of CDla + D-Ix before and after 
culture. Mean fluorescence intensities  (MFI) of a given an- 
tigen were measured for 12-d D-Ix and for D-Ix cultured 
for an additional 4 d on either CD32 L ceils (D-Ix 4 d CD32) 
or CD40L L cells (D-Ix 4 days CD4OL). This permitted us 
to calculate  for a  given antigen  two ratios:  Rc~3z =(MFI 
D-Ix 4  d  CD32)/(MFI  12-d D-Ix)  and  RCD40L =  (MFI 
D-Lc 4 d CD40L)/(MFI 12-d D-IX). Table 1 represents mean 
ratio values calculated from six independent experiments. A 
value ~1.8 represents a significant increase in antigen expres- 
sion while a value <0.5 represents a significant decrease in 
antigen expression. In all conditions, cells were CD14-  and 
CD15-  (not shown) but, upon CD40 engagement  the in- 
tensity of CDla  decreased significantly (P'c.D~L  "  0.5  + 
0.1). The Fc3' receptor Fc3,1LIII (CD16), expressed on 12-d 
D-IX was not specifically affected by culturing upon CD40L 
L cells. A slight increase of F~KII (CD32) expression was 
detected on 12-d D-IX recultured both on CD32 and CD40L 
L cells (Table 1). The FceKII (CD23) absent on 12-d D-IX 
was not upregnlated by culturing upon CD40L L cells (Table 
1). Likewise, neither the (x (CDlla) nor the fl (CD18) chain 
of the LFA- 1 complex were affected significantly.  In contrast, 
the counter-receptor intercellular  adhesion molecule 1 (ICAM- 
1) (CD54), was lost on CD32 L calls (Rcmz  =  0.2  +  0.1), 
but  was maintained  on  CD40L  L  cells (P,  cD~L ~'  0.8  • 
0.2). Concerning the other integrins, CD40 ligation upregu- 
lated CDllc  (RcrmL  =  2.7  +  1.0),  but not  the comple- 
ment receptor CR3 (CDllb) (Kcr~  -  0.8  •  0.2). In re- 
sponse to CD40 triggering,  the accessory molecules LFA-3 
(CD58) and B7-1 (CDS0) were increased (Kc.gmL -  3.9  • 
3.1 and 3.1  •  1.8 respectively). In addition the alternative 
1265  Canx et al. Fil;m'e 3.  L ~  ~  with CD40L induce  morphological  change  of CDh + D-I,c:  phase  contrast  obua'vation. 12-d  CDla  + D-I.c  were  PAC_~ 
sorted, then cultured  for 4 d either  on CD32 L cells (/1) or CD40L L cells (/3), in absence  of GM-CSF. Original magnification, x200. 
ligand for CD28/CTLA4, B7-2 (CD86), was strongly up- 
regulated by CD40 ligation (Kcm0L =  22.2  _+  13.5). The 
expression of  a third ligand for CD28/CTLA4 as determined 
by CTLA4-Ig binding in presence of competing anti-CD80 
and anti-CD86 mAbs was never detected (not shown). Ad- 
ditionally, CD40 ligation enhanced the expression of all the 
MHC class II molecules (RcD~  -- 3.0  +  2.4 for HLA-DK, 
8.8  +  5.7 for HLA-DP, and 7.0 +  5.3 for HLA-DQ). Note 
that CD40 engagement upregulated CD40 expression when 
compared to the initial population (Kcm0L =  2.0  +  0.2). 
Importantly CD40 triggering induced D-Ix: to express the 
low affinity IL-2 receptor cz chain Tac (CD25)  (tLcm0L '~ 
5.0 +  2.6), which, in vivo, is detected on interdigitating den- 
dritic cells of secondary lymphoid organs. These alterations 
of phcnotype, similarly observed in absence of  GM-CSF (not 
shown) were due to CD40 triggering, and could be detected 
at day 2 (not shown) but were more marked at day 4. 12-d 
D-I.c cultured with GM-CSF and CD32 L cells or with GM- 
CSF alone display similar phcnotypes (not shown) indicating 
that CD32 L cells represent  an inactive control. 
Thus, upon CD40 triggering, D-Lc maintain high levels 
or upregulate accessory  molecules involved in T cell costimu- 
lation (CD54, CD58, CD80, CD86, HLA class II) and ac- 
quire surface CD25/Tac. 
CD#O-actimted D-I.c Produce  a Restricted  Set of  Cytokees.  As 
CD40-activated monocytes and B cells were described to se- 
crete cytokines (20, 33), we investigated whether CD40 cross- 
linking also induced D-Lc to produce cytokines. Thus, cul- 
tured D-Lc seeded at 5  x  10S/ml  were either unstimulated 
or stimulated with a combination of PMA and ionomycine 
(PMA+ Iono) or with CD40L-transfected L calls. Four popu- 
lations of cells were actually analyzed that included (a) un- 
separated cultured cells which contained CDla + D-Lc  as 
well as CDla- ceils including monocytes/macrophages; (b) 
sorted CDla + D-Lc (>98% pure);  (c) sorted CDla-  cells 
(>98% pure); and (d) elutriated blood monocytes. Levels of 
TNF-cx, IL-lo~, IL-I~, IL-4, IL-6, IL-8, IL-10, GM-CSF, 
and MIP-la were measured in cell supernatants  harvested 
after 2 d. Table 2 shows the ranges from 10 independent ex- 
periments.  Unseparated  cultured cells and sorted CDla- 
calls were found to produce high levels of  TNF-a (1-30 ng/ml, 
n  =  6), IL-6 (0-8 ng/ml), IL-8 (1-30 ng/ml); and MIP-lc~ 
(1-30  ng/ml) after activation  with both PMA+Iono and 
CD40L L cells. In contrast, IL-lcr  (0-0.3  ng/ml), IL-lfl 
(0.2-0.4 ng/ml), and GM-CSF  (0.6-4.1  rig/m1) were pro- 
duced only  upon P/vIA+ Iono activation. IL-10 and 1I,-4 were 
never produced by any D-Lc population, regardless of the 
mode of activation. FACS~  CDla+CD14 -  cells were 
1266  CD40-dependent  Activation  of  Human Dendritic  Cells Figure 4.  L cells transfected with CD40L induce morphological change of CDla + D-IX: May O~nwald Oiemsa staining. 12-d CDla  § D-IX were 
FACS  ~ sorted,  then cultured for 4 d either on CD32 L cells (A) or CD40L L cells (B), in presence of GM-CSF. May Grflnwald Oierusa staining 
of the cultured cells is illustrated.  Original magnification,  ￿ 
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Figure 5.  CD40 triggering induces maintenance or upregulation of high levels of accessory molecules. 12-d D-Lc were cultured for 4 days either 
on CD32 L cells (D-Ix 4 d CD32) or CD40L L cells (D-Ix 4 d CD40L), in the presence of GM-CSE Then, cells were processed for double staining 
using a panel of mAb revealed by PE-conjugated anti-mouse Ig followed by FITC anti-CDla (OKT6) after saturation in 2% mouse sera. The figure 
represents the staining of the mAbs on the CDla § cells at day 12, and after 4 d on CD32 L cells, or CD40L L cells. Vertical lines conesponding 
to the peak channel of fluorescence intensity  of a given antigen on 12-d D-Lc have been drawn to allow the comparative analysis of antigen expression 
levels on day 12 D-Lc that undergo different secondary culture conditions. 
1267  Caux et al. Table  1.  Modulation of the Expression of Antigens by Culturing D-Lc over CD32 or CD40L  L  Cells 
Ratios:  MFI of cultured cdls/MFI of 12-d D-Lc 
RcmJD-Lc 4 d  CD32  RCD~/D-Lc 4 d  CD40L 
Lineagt~-spccific antigens 
IgG1  0.9  •  0.2  1.4  •  0.2 
CDla  1.0  •  0.1  0.5  •  0.2 
CD14  1.1  •  0.4  0.9  •  0.2 
CD15  1.2  •  0.3  1.4  +  0.3 
Fc receptors 
CD16 (Fc'y Kill)  0.9  •  0.1  1.2  •  0.2 
CD32 (Pc')' KiI)  2.2  •  0.2  1.8  +  0.4 
CD23  (Fc~ KiI)  1.1  •  0.2  1.2  •  0.3 
Costimulatory molecules 
CD11a (LFA-lc~)  1.3  •  0.3  1.4  +  0.2 
CDllb  (CR.III)  0.8  •  0.3  0.8  •  0.2 
CD11c  1.2  •  0.3  2.7  •  1.0 
CD18 (LFA-I~)  1.1  •  0.3  1.2  +  0.1 
CD54 (ICAM-1)  0.2  •  0.1  0.8  •  0.2 
CD58  (LFA-3)  0.7  •  0.3  3.9  •  3.1 
CD80 (B7-1)  1.1  •  0.2  3.1  •  1.8 
CD86  (B7-2)  1.8  •  0.4  22.2  •  13.5 
MHC molecules 
HI,A-DR  0.8  •  0.1  3.0  •  2.4 
HLA-DP  1.1  •  0.6  8.8  •  5.7 
HLA-DQ  1.0  •  0.4  7.0  •  5.3 
Activation antigens 
CD25  (TAC)  1.2  •  0.1  5.0  •  2.6 
CD40  0.8  •  0.2  2.0  •  0.2 
12-d D-Lc were cultured for 4 days either on CD32 L cells (D-Lc 4 d CD32) or CD40L L ceils (D-Lc 4 d CD4OL), in ~ce  of GM-CSF. Cells 
were then processed for double staining using a pant of mAbs revealed by PE-conjugetcd anti-mouse Ig followod by FITC anti-CDla (OKT6) 
after saturation in 2% mouse sera. MFIs of a given antigen were measured before arai after culture. The following ratios were calculated: gc..D32 
-  (MFI D-Lc 4 d CD32)/(MFI  12-d D-I,c) and Kcr~0t -  (MPI D-Lc 4 d CD40L)/(MFI 12-d D-Lc). Values represent mean +  SD of ratio from 
six independent experiments. A value ;~1.8 represents a significant inczease in antigen expression  whereas a value g0.5 represents a significant decrease 
in antigen expression. 
found to produce high levels of TNF-o~ (2-10 ng/ml),  IL-8 
(3-17 ng/ml), and MIP-la (~30 ng/ml) and significant levels 
of IL-I~ (0.1-0.5 ng/ml)  and GM-CSF  (0-1.1  ng/ml) but 
no IL-6 (0 ng/ml) upon PMA+ Iono activation. Upon CD40 
triggering, CDla + cells were found to produce only TNF-c~ 
(0.6-4.5 ng/ml), IL-8 (0.6-2.5 ng/ml), and MIP-lc~ (0.5-1.1 
ng/ml).  When  cells  were cultured  on  CD32  L  cells,  no 
significant  induction  of cytokine production was  detected 
when compared with medium alone (not shown). As a posi- 
tive control, dutriated monocytes were found to produce high 
levels of TNF-cx,  IL-lc~,  IL-I~,  IL-6,  IL-8, MIP-lc~,  and 
IL-10 upon CD40 activation. Upon CD40 triggering, elutri- 
ated monocytes were never found (from day 2 to 6) to display 
the typical morphology of D-I.c, even in presence of GM- 
CSF (not shown). 
Thus,  CDla + D-Lc produce a restricted set of cytokines 
(TNF-ol, IL-I~, IL-8, and MIP-lc~) under nonspecific acti- 
vation and only TNF~,  IL-8, and MIP-lot under CD40 c~oss- 
linking. 
CD40L Is Upregulated on T  Cells during a Cognate Interac- 
tion with D-Lc.  As D-Lc are powerful activators of T  cells, 
we investigated whether CD40L was upregnlated on T  cells 
during an MHC-restricted interaction with D-I.c. To address 
this question, allospecific CD4 + T  cell lines were established 
1268  CD40-dependent  Activation of" Human Dendritic Cells Table  2.  CD40  Triggering of CDla + D-Lc Induces TNF~,  IL-8,  and MIP-lcr  Production 
Cells  Activation  TNF-c~  IL-6  IL-lc~  IL-1/3  IL-4  IL-10  GM-CSF  IL-8  MIP-lo~ 
ng/ml 
Medium  0-0.2  <0.05  <0.05  <0.05  <0.05  <0.05  <0.05  0.1-0.4  0-0.1 
12-d D-Lc  PMA  +  Iono  3.1-30  1.3-8.4  0.1-0.3  0.3-0.4  <0.05  <0.05  0.9-4.1  3.7-30  ~30 
CD40L  1.0-2.3  0-3.3  <0.05  <0.05  <0.05  <0.05  <0.05  0.7-5.7  2.1-30 
Medium  0-0.1  <0.05  <0.05  <0.05  <0.05  <0.05  <0.05  0-0.2  0.1-0.2 
CDla + D-Lc  PMA  +  Iono  1.9-10  <0.05  <0.05  0.1-0.5  <0.05  <0.05  0-1.2  3.5-17  )30 
CD40L  0.6--4.5  <0.05  <0.05  <0.05  <0.05  <0.05  <0.05  0.6-2.5  0.5-1.1 
Medium  0-0.1  <0.05  <0.05  <0.05  ND  <0.05  <0.05  0.4-1.0  0.2-0.4 
CDla-cells  PMA  +  Iono  1.4-5.5  1.2-2.0  <0.05  0.2-0.4  ND  <0.05  0.6-1.8  3.9-11.9  8.7-~30 
CD40L  0.2-2.1  0--0.8  <0.05  <0.05  ND  <0.05  <0.05  0.8-7.6  0.8-6.4 
Medium  0.1-0.2  <0.05  <0.05  <0.05  ND  <0.05  <0.05  4.0-4.4  0.1-0.3 
Monocytes  PMA  +  Iono  1.1-2.3  1.7-3.2  ND  ND  ND  ND  <0.05  6.2-23.2  2.5-3.5 
CD40L  1.3-3.5  3.7-15.9  0.5-1.1  0.1-6.9  ND  1.2-2.6  <0.05  8.0-9.5  6.1-6.5 
After 12 d of culture in the presence of GM-CSF + TNF-ot, total D-Ix, FACS  ~ sorted CDla + D-IX  or FACS  |  sorted CDla- cells  were cultured 
for 48 h either in medium alone, PMA (1 ng/ml) plus ionomycine (1/tg/ml), or CD40L L cells, in the absence  of GM-CSE Elutriated monocytes 
were used as positive control. Cytokine levels were determined by two-site sandwich ELISAs. Results are expressed in ng/ml and represent ranges 
of cytokine production obtained in 10 unrelated experiments. 
by repeated cultures on the same D-Lc samples (as described 
in Caux, C., C. Massacrier, C. Dezutter-Dambuyant, R  Van- 
bervliet, C. Jacquet, D. Schmitt, and J. Bancherean, manu- 
script in preparation). After two rounds of expansion on D-l,c 
originating  from  a  single  cord blood,  the  CD4 +  T  ceils 
were activated for 24 h  either with immobilized anti-CD3 
or with the allospecific D-Lc (10  s D-Lc for 106 T  ceils/ml) 
and then analyzed for their expression of CD71 (as a control 
of cellular activation) and CD40L (using biotinyhted CD40-Ig 
fusion molecule) (Fig.  6).  In the absence of any activation, 
T  ceils lacked both CD71 and CD40L, whereas upon anti- 
CD3 activation, T cells upregulated CD71 as well as CD40L. 
In contrast, when D-Lc were used as stimulators, CD71 was 
upregulated reaching levels observed during anti-CD3 acti- 
vation, while CD40L remained undetectable. However, the 
lack of CD40-Ig binding may be due to saturation of CD40L 
with a soluble form of CD40 as observed earlier with B ceils 
(28). This is particularly relevant because D-Lc supernatants 
were found  to  contain  significant  levels  of soluble  CD40 
(sCD40) (not shown). Thus, to determine whether D-k-de 
rived sCD40 might prevent the CD40L detection on acti- 
vated T cells, an anti-CD40 (mab-89) mAb was added to the 
medium during the 24 h of D-Lc/T ceil coculture as it pre- 
vents binding of sCD40 to CD40L (28).  In this case,  high 
levels of CD40L could be detected on D-I,c-activated T cells 
(Fig. 6, right).  When mAb-89 was added to either nonacti- 
vated or anti-CD3-activated T  ceils,  no changes in  CD71 
nor  CD40L  expression  were  detected  (not  shown).  The 
D-Lc-induced  upregulation  of  CD40L  on  T  calls  was 
confL,-med in a primary reaction using a cocktail of superan- 
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Figure 6.  D-l.c-dependent  activation  of allospecitic  CD4 + T cells in- 
duces CD40L upreguhtion. Allospecific  CD4 § T cell lines were estab- 
lished by repeated  cultures on the same  D-I.c sample (Caux, C., C. Mas- 
sacrier, C. Dezutter-Dambuyant,  B. Vanbervliet,  C. Jacquct, D. Schmitt, 
and J. Bancherean, manuscript in preparation). After two rounds of e~- 
pansion on the same  D-l.c, the CD4 § T cells were activated  for 24 h ei- 
ther with immobilized  anti-CD3 or with the allospecitic  D-Ix (10  s D-I.c 
for 106 T ceUs/ml) in presence or absence  of anti-CD40 (mAb 89) and 
then analyzed for CD71 (control of activation) and CD40L (using bi- 
otinyhted CD40-Ig fusion molecule) expression. D-I.c were excluded by 
gating on smaller  size  cells. The presence  of  anti-CD40 mAb during anti- 
CD3 activation of T cells did not affect CD71 nor CD40L expression 
(not shown). An isotype match mAb did not affect CD71 nor CD40L 
expression in any condition (not shown). tigens (Staphylococcal  enteromxins A, 13, C-1, D, and E) which 
allows activation of more than 70% of peripheral blood resting 
T  cells (not shown). Furthermore, the CD40L expression 
was also detected by a rabbit polyclonal anti-CD40L (15) 
binding to epitopes not involved in CD40/CD40L interac- 
tions (not shown). 
Thus, D-l.c can turn on CD40-L expression on interacting 
with T  cells that may, in return, signal D-I.c. 
Discussion 
The present study demonstrates that dendritic cells derived 
from CD34 + HPC express high levels of functional CD40. 
CD40  triggering of D-I_c enhances cell survival,  induces 
striking morphological changes, maintains or increases high 
levels of accessory molecules and turns on the production of 
a restricted set of cytokines. Therefore, the expression of a 
functional CD40 on dendritic cells is in line with the func- 
tional role of CD40 on all positive cells studied to date (18--20). 
As cognate interaction between D-Lc and T  cells results 
in CD40L upregulation on T cells, CD40 triggering of den- 
dritic cells is likely to occur during an antigen-dependent in- 
teraction with T  cells in the paracortical  T  cell-rich areas 
of secondary lymphoid organs. Accordingly, after in vivo im- 
munization, CD40L is mainly expressed on T  cells in the 
periarteriolar lymphocyte sheats (34). CD40/CD40L inter- 
actions result in enhanced D-Lc survival  that will permit 
prolonged dendritic cell/T cell interactions. In this context, 
the maintenance of high levels of HLA class II antigens and 
upregnlation of accessory molecules such as CD58 and CD28 
ligands (B7-1/CDS0; B7-2/CD86) will concur to a strong 
T cell activation. The most dramatically upregulated acces- 
sory molecule turned out to be B7-2 (CD86), the alternative 
ligand for CD28/CTLA-4 which plays a predominant role 
in dendritic cell dependent T cell activation as shown elseo 
where (35). The CD40 dependent extension of plasma mem- 
brane surface may facilitate further interactions of D-I.c with 
other antigen-specific immune cells such as CD8 T cells or 
B cells. In this context, upon CD40 engagement D-I.c pro- 
duce MIP-lot  and  IL-8,  cytokines characterized  by  their 
chemotactic activity. Their production by activated dendritic 
cells may indeed contribute to the recruitment of these im- 
mune cells, in secondary lymphoid organs.  It will thus be 
important to establish the full repertoire of chemokines secreted 
by activated D-Lc and to determine the cell types chemoat- 
tracted by activated DC. In addition to MIP-lc~ and IL-8, 
D-I.c were found to secrete significant amounts of TNF-ol 
upon CD40 engagement and IL=l/5 and GM-CSF in response 
to phorbol esters  +  ionomycine. TNl~-ot may be secreted 
either to enhance the activation of antigen selected B cells 
(36-38) or to induce apoptosis (39,  40) of bystander T  or 
B cells. These cytokines may also play an autocrine role in 
D-Ix activation. This set of secreted cytokines is consistent 
with the production of IL-1/5 and MIP-lcx by fresh Lange- 
rhans cells (41). However, until now, Langerhans cells have 
never been reported to produce TNF-ot, but this lack of in- 
formation may merely be due to the difficulty to obtain pure 
populations of dendritic cells. In view of the present study, 
the ability of freshly isolated dendritic ceils to secrete TNF-c~ 
and IL-8 will require further analysis. It should be stressed 
that under similar experimental conditions, monocytes pro- 
duced more of these cytokines as weU as large amounts of 
IL-lc~, IL-1/~, IL-6, and IL-10. This striking difference be- 
tween D-Ix and monocytes regarding cytokine production 
may be relevant  to either monocyte/macrophage functions 
in nonantigen-specific cellular immunity  or to a role of mono- 
cytes in skewing of T cell differentiation. Indeed the lack of 
influence of dendritic cells on commitment towards either 
TH1 or TH2 during primary T cell activation (42, 43) may 
be due to the limited repertoires of cytokines secreted by den- 
dritic cells. 
It is interesting to note that upon CD40 activation, D-Lc 
express CD25/Tac, an event that is observed after cells have 
migrated from the epidermis (22, 44-46). Likewise, the CD40- 
dependent downregnlation of CDla observed herein also 
occurs in vivo during migration of DC from the periphery 
into the secondary lymphoid organs (22, 47). Thus, the ex- 
pression of CD25 and lack of CDla on interdigitating den- 
dritic cells may be a consequence of CD40 triggering. Actu- 
ally, it is all'cult to estimate whether this phenotypic alteration 
occurs in the paracortical  areas or in the periphery after en- 
counter with  CD40L-expressing cells.  In the latter case, 
CD40L-expressing cells may be either activated  T  cells or 
basophils (48). In any case, it will be important to determine 
whether  CD40-activated  DC  express  high  affinity  IL-2 
receptors and if so what signals does IL-2 provide them with. 
Hyper IgM patients disphy clinical symptoms suggestive 
of immune alterations  not limited to B cells (49). In partic- 
ular, the frequent Pneumocystis carenii infections indicate im- 
paired T  cell functions that might stem from altered den- 
dritic cdl/T cell interactions as would predict the present 
study. Altered CD40L might result in incomplete dendritic 
cell activation and consequently impaired T ceU activation. 
Alternatively, since cross-linking of T cell CD40L contributes 
to development of cytotoxicity in naive T cells (50), cells with 
altered CD40L might not receive optimal signals for the full 
development of their cytotoxic potential. 
Thus, as well as B cells, monocytes and thymic stroma, 
dendritic cells display functional CD40 molecules. 
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